Immix Biopharma Inc. to Present and Meet Investors at the 37th Annual Piper Sandler Healthcare Conference
Reuters
Oct 01, 2025
<a href="https://laohu8.com/S/IMMX">Immix Biopharma</a> Inc. to Present and Meet Investors at the 37th Annual Piper Sandler Healthcare Conference
Immix Biopharma Inc., a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, will present and host institutional investor meetings at the 37th Annual Piper Sandler Healthcare Conference, taking place December 2-4, 2025, at the Lotte New York Palace Hotel in New York. A replay of the presentation will be available on the Immix website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immix Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9538191-en) on October 01, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.